retatrutide clinical trial duration Eli Lilly's Phase 3 studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments Retatrutide Phase 3: TRIUMPH Program

Does insurance cover Ozempic

Cervantes-Barragan, L

The takeaway This new VA research adds to a growing body of evidence: GLP-1s arent just about weight loss theyre reshaping what long-term health can look like

Fortune also spoke with five people who had stopped taking GLP-1 medicationsall of whom said they started regaining the weight they had lost when they stopped taking the medications and their food cravings returned

Still, theres promising evidence that the supplement may change the brain and nervous system in a way that helps lessen symptoms of: Major depressive disorder Schizophrenia Bipolar disorder Posttraumatic stress disorder (PTSD) Obsessive-compulsive disorder Trichotillomania (hair pulling) Substance use disorders Some studies show that the supplement may help ease symptoms of withdrawal, including a strong urge or craving to take drugs

(2024) A review of therapies for hyperpigmentation modulating the synthesis of eumelanin to pheomelanin, Archives of Dermatological Research, [online]